Viewing negative mentions of gene expression of HLA-DRB1 (H. sapiens) in T cells

Full-text article links are indicated by after the article reference.

Document Target Regulator Anatomy Sentence
Biancotto et al. (2008)HLA-DRT cellsIn this system, HIV-1 readily infects various CD4+ T cells, but productive viral infection was supported predominantly by activated T cells expressing either CD25 or HLA-DR or both (CD25/HLA-DR) but not other activation markers: There was a strong positive correlation (r=0.64, P=.001) between virus production and the number of CD25+/HLA-DR+ T cells.
Carosella et al. (1981)HLA-DRT cellsWe observed that: (1) Suppressor cells obtained after in vitro priming and their precursors are adherent to glass wool, whereas cytotoxic cells and their precursors are not; (2) primed cells adherent to glass wool are mainly HLA-DR positive, while nonadherent cells are HLA-DR negative or weakly positive; (3) the nonadherent, unprimed T cells used as responder cells in a primary MLR are more readily suppressed by suppressor cells than the same cells unfiltered.
Morelli et al. (1994)HLA-DRT cellsMost of the T cells were HLA-DR negative.
Al-Katib and Koziner (1984)HLA-DRT-cellLeu-10, like HLA-DR, was absent from T-cell acute lymphoblastic leukaemia (ALL) (two cases).
Sandalova et al. (2010)HLA-DRT cellsThese results were obtained in subjects receiving attenuated virus vaccines (Smallpox and Yellow Fever), and activation (CD38/HLA-DR) and proliferation markers (Ki-67/Bcl-2 low) were only expressed by CD8 T cells specific for the vaccine but not by CD8 T cells of different specificities.
Dao et al. (2009)DR-1 peptideT cellsWe found that the DR-1 stimulated CD4 T cells were also able to kill autologous DCs pulsed with DR-1 peptide, but not un-pulsed DCs or DCs pulsed with irrelevant DR1-binding peptide JAK2-DR.
Savage et al. (1993)HLA-DRT cellsHLA-DR-expressing EC alone appear sufficient to stimulate purified CD4+ T cell proliferation without the involvement of other leukocyte populations, as indicated by the following observations: (1) we find no contaminating leukocytes in our EC cultures by FACS analysis or fluorescence microscopy; specifically, there are no detectable CD45 or HLA-DR expressing cells; (2) neither the EC cultures nor the purified CD4+ T cells contain HLA-DR expressing cells detectable by polymerase chain reaction (PCR) of reverse-transcribed mRNA; (3) the stimulatory capacity of the EC cultures is maintained through serial subculture and through low-density replating, indicating that the stimulatory cell type must proliferate in culture as well as EC; and (4) in contrast to MLRs, the response to EC cultures is not inhibited by pretreatment of the stimulator cells and/or responding T cells with the monocyte toxin L-leucine-O-methyl ester.
West et al. (2006)HLA-DR10-negativeT-cellMicromolar concentrations of all three SHALs showed binding to Raji, an HLA-DR10-positive human malignant B-cell line but no binding to CEM or Jurkat's, HLA-DR10-negative malignant T-cell lines.
Masuda et al. (1994)HLA-DRT cellPMT-2Y cells are positive for CD2, CD3, CD4, CD25, T cell receptor alpha beta and HLA-DR, but negative for CD1, CD7, CD8, CD19 and CD20, indicating that the clone belongs to a helper/inducer subset of T cells.
Ramesh et al. (1992)HLA-DRT cellsThis premise was further confirmed by demonstrating that mouse L cells transfected with human HLA-DR, but not HLA-DP or DQ molecules, supported the proliferation of purified T cells to peptide 2.
Pang et al. (1995)HLA-DRT cellsIn sputum, T cells were of a minor population (< 2% of total cells), and not all expressed activation markers for CD29 (very late antigen-1 (VLA-1)), IL-2R and HLA-DR.
Welch et al. (1986)HLA-DRT-cellTumor cell characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studies revealed that the tumor cells expressed OKM1 and MMA (Leu-M1), but not HLA-DR, B-, or T-cell markers.
Christmas et al. (1992)DRw15T cellsThis suggests that V beta 8+ T cells are not predominantly reactive against DR2 (DRw15).
Wang et al. (2010)HLA-DRB1T-cellWe identified a novel HLA-DR4-restricted CD4+ T-cell epitope on a secreted antigen of Mycobacterium tuberculosis, MPT51, in 004149-MM HLA-DR4-transgenic mice which express HLA-DRB1*0401, but not murine MHC class II molecules.
Mohamed et al. (1992)HLA-DRT-cellIn the primary sample the majority of blast cells displayed the early T-cell markers, CD7, HLA-DR, and TdT, but were negative for the common ALL antigen (CALLA), CD4 and CD8.
Soler et al. (1994)anti-HLA-DRT-cellThe immunophenotype study showed that the leukaemic cells were positive for CD2, CD38, CD56 and anti-HLA-DR monoclonal antibodies and negative for other T-cell (CD3, CD4, CD8) and B-cell markers (CD19, CD20 and surface immunoglobulins).
Ohyama et al. (2001)HLA-DRB1 moleculeT cellThus, it appears that T cell response to MMP II is restricted by the HLA-DRB1 molecule, but not by DQ and DP molecules, which results in the induction of IFN-gamma production.